The Gut Microbiome: From Microbial Metabolism to Human Biology
The human gastrointestinal tract is home to one of the most diverse biological ecosystems on Earth. Collectively known as the gut microbiome, this vast community of bacteria, archaea, fungi, and viruses contains trillions of microorganisms that coexist with their human host. Although these microorganisms represent only a small fraction of our body mass, they possess an enormous collective metabolic capacity, producing thousands of chemical compounds that influence the biochemical environment of the intestine and beyond.
The human gastrointestinal tract is home to one of the body's most complex biological ecosystems. Beyond its established roles in digestion and nutrient absorption, the intestine serves as a dynamic interface between diet, host physiology, and trillions of resident microorganisms collectively known as the gut microbiome. Through their extensive metabolic activity, these microorganisms transform dietary components into hundreds of small molecules that contribute to the biochemical environment of the intestine and, in many cases, enter the systemic circulation.
Over the past two decades, advances in molecular biology, analytical chemistry, and computational biology have transformed our understanding of the gut microbiome. Rather than viewing microorganisms simply as passive inhabitants of the digestive tract, researchers now recognize them as a metabolically active ecosystem whose biochemical activities contribute to numerous aspects of human physiology.
A Metabolically Active Ecosystem
Unlike human cells, intestinal microorganisms possess an extraordinary diversity of enzymes capable of transforming dietary components that escape digestion in the upper gastrointestinal tract.
Complex carbohydrates, dietary fiber, proteins, amino acids, bile acids, and plant-derived polyphenols all become substrates for microbial metabolism. Through fermentation and enzymatic conversion, these compounds are transformed into hundreds of small molecules collectively referred to as microbial metabolites.
These metabolites represent the functional output of the gut microbiome. While DNA sequencing can identify which microorganisms are present, metabolite analysis provides insight into the biochemical activity occurring within the microbial ecosystem at the time of sampling.
For this reason, metabolomics has become an increasingly important complement to microbiome sequencing in both basic and applied research.
Microbial Metabolites and Host Physiology
Many microbial metabolites are absorbed from the intestine into the circulation, where they may interact with tissues throughout the body. Our understanding of their biological activities continues to evolve, with new metabolic pathways and molecular interactions being described as research progresses.
Among the best-characterized classes of microbial metabolites are:
Short-chain fatty acids (SCFAs), produced primarily through fermentation of dietary fiber.
Indole compounds, generated through microbial metabolism of the amino acid tryptophan.
Secondary bile acids, formed through bacterial modification of primary bile acids.
Phenolic metabolites, originating from dietary polyphenols.
Together, these compounds illustrate the complex biochemical interactions that occur between the gut microbiome and its human host.
Tryptophan: A Shared Metabolic Pathway
One well-studied example of host–microbe interaction involves the essential amino acid tryptophan.
Humans obtain tryptophan through the diet, after which it enters several distinct metabolic pathways. Some pathways are mediated primarily by human enzymes, while others depend on microbial metabolism within the intestine.
This shared metabolism gives rise to a diverse family of compounds, including kynurenines and indole derivatives. Among these, indole-3-propionic acid (IPA) has attracted considerable scientific interest because it is produced by specific intestinal bacteria and illustrates the close biochemical relationship between microbial metabolism and host physiology.
Although many biological activities of microbial tryptophan metabolites remain under investigation, these compounds have become valuable tools for studying interactions between diet, microorganisms, and human biology.
Measuring Biological Chemistry
Understanding microbial metabolism requires analytical methods capable of measuring chemically diverse compounds at very low concentrations.
Modern analytical laboratories employ high-performance liquid chromatography (HPLC), liquid chromatography–mass spectrometry (LC–MS/MS), gas chromatography (GC), and other advanced analytical techniques to separate, identify, and quantify metabolites in biological samples.
These technologies have dramatically expanded researchers' ability to investigate metabolic pathways that were previously difficult—or impossible—to characterize. As analytical sensitivity has improved, increasingly complex metabolic networks can now be studied across large populations and diverse biological samples.
Dried Blood Spot Sampling
Among the technologies that have facilitated large-scale metabolic studies is dried blood spot (DBS) sampling.
Originally introduced for newborn screening more than half a century ago, DBS technology has evolved into a widely used sampling approach for numerous types of biochemical analysis.
After collection, blood is absorbed onto standardized filter paper where many analytes remain stable during storage and transportation. This simplifies sample logistics and enables studies involving geographically dispersed populations without the need for immediate sample processing.
When combined with validated analytical methods, DBS provides a practical sample matrix for quantitative laboratory analysis of numerous metabolites.
From Biology to Analytical Science
The growing understanding of the gut microbiome has been driven by advances across multiple scientific disciplines, including microbiology, biochemistry, analytical chemistry, systems biology, and computational science.
As new analytical technologies continue to emerge, researchers are gaining an increasingly detailed picture of how microbial metabolism contributes to the complex biochemical environment of the human body. Rather than focusing solely on identifying microbial species, modern research increasingly emphasizes understanding microbial function through the measurement of metabolites and biochemical pathways.
This shift—from cataloguing microorganisms to characterizing their metabolic activity—represents one of the most significant developments in microbiome research over the past decade.
Analytical Expertise at Vitas
Vitas AS is an independent contract analytical laboratory specializing in the quantitative analysis of small molecules in biological samples.
Our laboratories develop, validate, and perform high-throughput analytical methods using technologies including LC–MS/MS, HPLC, GC–FID, ICP–MS, immunoassays, and dried blood spot (DBS) methodologies. These analytical platforms support pharmaceutical development, nutritional research, clinical research, environmental studies, and other scientific applications requiring robust quantitative laboratory analysis.
Related Analytical Method
The tryptophan-derived metabolites discussed in this article can be quantified using validated chromatographic methods.
At Vitas AS, these metabolites are determined using the validated quantitative LC-FLD/UV method AM-654. The method quantifies several compounds within the tryptophan metabolic pathway, including tryptophan (TRY), kynurenine (KYN), indole-3-propionic acid (IPA), and related metabolites from a single dried blood spot (DBS) sample.
A detailed description of the analytical principle, sample preparation, validation, and analytical performance is available on the dedicated method page.
→ AM-654: Quantitative Analysis of Tryptophan-Derived Metabolites in Dried Blood Spots
References
Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature. 2012;486:207–214. doi:10.1038/nature11234.
Integrative HMP (iHMP) Research Network Consortium. The Integrative Human Microbiome Project. Nature. 2019;569:641–648. doi:10.1038/s41586-019-1238-8.
Nicholson JK, Holmes E, Kinross J, et al. Host–Gut Microbiota Metabolic Interactions. Science. 2012;336:1262–1267. doi:10.1126/science.1223813.
Koh A, De Vadder F, Kovatcheva-Datchary P, Bäckhed F. From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites. Cell. 2016;165:1332–1345. doi:10.1016/j.cell.2016.05.041.
Agus A, Planchais J, Sokol H. Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease. Cell Host & Microbe. 2018;23:716–724. doi:10.1016/j.chom.2018.05.003.
Wikoff WR, Anfora AT, Liu J, et al. Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proceedings of the National Academy of Sciences USA. 2009;106:3698–3703. doi:10.1073/pnas.0812874106.
Tremaroli V, Bäckhed F. Functional interactions between the gut microbiota and host metabolism. Nature. 2012;489:242–249. doi:10.1038/nature11552.
Cryan JF, O'Riordan KJ, Cowan CSM, et al. The Microbiota–Gut–Brain Axis. Physiological Reviews. 2019;99:1877–2013. doi:10.1152/physrev.00018.2018.
Turnbaugh PJ, Ley RE, Hamady M, et al. The Human Microbiome Project. Nature. 2007;449:804–810. doi:10.1038/nature06244.
Sender R, Fuchs S, Milo R. Revised Estimates for the Number of Human and Bacteria Cells in the Body. PLoS Biology. 2016;14:e1002533. doi:10.1371/journal.pbio.1002533.
Louis P, Flint HJ. Formation of propionate and butyrate by the human colonic microbiota. Environmental Microbiology. 2017;19:29–41. doi:10.1111/1462-2920.13589.
Wishart DS. Emerging applications of metabolomics in drug discovery and precision medicine. Nature Reviews Drug Discovery. 2016;15:473–484. doi:10.1038/nrd.2016.32.